Cilioretinal artery occlusion: An ocular complication of primary antiphospholipid syndrome

Retina

Volumn 17, Issue 6, 1997, Pages 555-557

  Dori, Dalia ^a   Gelfand, Yuval A ^a   Brenner, Benjamin ^a,b   Miller, Benjamin ^a,b  

^a RAMBAM MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ENOXAPARIN; FLUOCORTOLONE; PHOSPHOLIPID ANTIBODY;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLOOD PLACENTA BARRIER; CASE REPORT; DEEP VEIN THROMBOSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; PATHOPHYSIOLOGY; RETINA ARTERY OCCLUSION; VISUAL ACUITY; VISUAL IMPAIRMENT;

EID: 0031464449     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-199706000-00013     Document Type: Article

References (7)

1. Khamashta MA, Cuadrado MJ, Mujic F, et al. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995;332:993-997.
2. Asherson RA, Merry P, Acheson JF, et al. Antiphospholipid antibodies: a risk factor for occlusive ocular vascular disease in systemic lupus erythematosus and the "primary" antiphospholipid syndrome. Ann Rheum Dis 1989;48:358-361.
3. Castanon C, Amigo MC, Banales JL, et al. Ocular vasoocclusive disease in primary antiphospholipid syndrome. Ophthalmology 1995;102:256-262.
4. Pulido JS, Ward LM, Fishman GA, et al. Antiphospholipid antibodies associated with retinal vascular disease. Retina 1987;7:215-218.
5. Glacet-Bernard A, Bayani N, Chretien P, et al. Antiphospholipid antibodies in retinal vascular occlusions: a prospective study of 75 patients. Arch Ophthalmol 1994;112:790-795.
6. Brown GC, Shields JA. Cilioretinal arteries and retinal arterial occlusion. Arch Ophthalmol 1979;97:84-92.
7. Hall S, Buettner H, Luthra HS. Occlusive retinal vascular disease in systemic lupus erythematosus. J Rheumatol 1984; 11:846-850.